Cancer cure finally here? New drug Dostarlimab cures all patients in trial ’first time in history’

In a small clinical trial, 18 patients took the drug Dostarlimab for six months, and all of them had their cancer vanished.

Edited By Sounak Mukhopadhyay
Updated8 Jun 2022, 09:24 AM IST
FILE - This undated fluorescence-colored microscope image shows a culture of human breast cancer cells. (Ewa Krawczyk/National Cancer Institute via AP)
FILE - This undated fluorescence-colored microscope image shows a culture of human breast cancer cells. (Ewa Krawczyk/National Cancer Institute via AP)(AP)

A small clinical trial discovered that every single rectal cancer patient who got an experimental treatment saw their disease vanish, in what looks to be a miracle and a "first in history". According to the New York Times, 18 patients took a medicine named Dostarlimab for six months in a limited clinical trial done by Memorial Sloan Kettering Cancer Center, and all of them saw their tumours shrink at the end.

Experts stated that the malignancy is undetectable by physical examination, endoscopy, positron emission tomography or PET scans, or MRI scans. This shows that Dostarlimab has the potential to be a 'possible' cancer cure for one of the most lethal tumours.

This is "the first time this has happened in the history of cancer," according to Dr. Luis A. Diaz J. of Memorial Sloan Kettering Cancer Center in New York. Dostarlimab is a medicine made in a lab that functions as a surrogate for antibodies in the human body, according to specialists.

According to the New York Times, individuals in the clinical experiment previously received treatments such as chemotherapy, radiation, and invasive surgery, all of which could cause bowel, urinary, and sexual dysfunction. The 18 patients expected to have to go through these surgeries as the next step in the research. However, they were surprised to learn that no more therapy was required. Experts were astounded by the trial's outcomes, stating that total remission in every single patient is "unheard-of."

Dr Alan P. Venook, who is a colorectal cancer specialist at the University of California, said that the complete remission in every single patient is "unheard-of". He hailed the research as "world-first".

Experts praised the study because not all of the participants experienced serious side effects from the medication trial.

"There were a lot of happy tears," said Oncologist Dr Andrea Cercek, describing the moment patients found out they were cancer-free as quoted by New York Times.

According to doctors, the patients, during the trial, took Dostarlimab every three weeks for six months. "It is noteworthy that they were all in similar stages of their cancer. The cancer was locally advanced in the rectum but had not spread to other organs," added doctors.

"At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up,' researchers wrote in the study published in the media outlet.

According to cancer researchers who studied the medicine, it appears to be promising, but a larger-scale trial is required.

(With ANI inputs)

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:8 Jun 2022, 09:24 AM IST
Business NewsNewsWorldCancer cure finally here? New drug Dostarlimab cures all patients in trial ’first time in history’

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Tata Steel share price

    149.70
    07:18 PM | 1 NOV 2024
    1.05 (0.71%)

    Indian Oil Corporation share price

    145.00
    07:19 PM | 1 NOV 2024
    2.3 (1.61%)

    Tata Power share price

    445.20
    07:19 PM | 1 NOV 2024
    5.15 (1.17%)

    Bandhan Bank share price

    183.65
    07:10 PM | 1 NOV 2024
    1.4 (0.77%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Rainbow Childrens Medicare share price

    1,545.00
    06:59 PM | 1 NOV 2024
    -67.25 (-4.17%)

    ICICI Securities share price

    833.45
    06:59 PM | 1 NOV 2024
    -32.85 (-3.79%)

    Vijaya Diagnostic Centre share price

    966.70
    06:59 PM | 1 NOV 2024
    -30.35 (-3.04%)

    Narayana Hrudayalaya share price

    1,235.60
    06:59 PM | 1 NOV 2024
    -36.75 (-2.89%)
    More from Top Losers

    Brigade Enterprises share price

    1,244.80
    07:19 PM | 1 NOV 2024
    71.75 (6.12%)

    PCBL share price

    432.15
    07:17 PM | 1 NOV 2024
    21.35 (5.2%)

    Piramal Pharma share price

    281.85
    07:17 PM | 1 NOV 2024
    13.45 (5.01%)

    Jubilant Pharmova share price

    1,273.00
    06:59 PM | 1 NOV 2024
    60.65 (5%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      81,355.000.00
      Chennai
      81,361.000.00
      Delhi
      81,513.000.00
      Kolkata
      81,365.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L-0.06
      Chennai
      101.23/L0.43
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in News

        HomeMarketsPremiumInstant LoanMint Shorts